![]() |
市场调查报告书
商品编码
1959875
膀胱容量压力测量导管市场-全球产业规模、份额、趋势、机会和预测:按产品、应用、最终用户、地区和竞争对手划分,2021-2031年Bladder Volume Manometer Catheter Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球膀胱容量测量导管市场预计将从 2025 年的 6.1648 亿美元成长到 2031 年的 8.4089 亿美元,复合年增长率为 5.31%。
这些专用医疗设备旨在透过膀胱测量腹内压,从而能够准确诊断高血压等疾病。这些设备提供重症监护管理所需的关键数据,并取代了不可靠的临床评估方法,已成为不可或缺的工具。市场成长的主要驱动因素包括:加护病房收治病患数量的增加、预防高腹压相关器官衰竭的迫切需求,以及创伤救治中对微创监测解决方案日益增长的需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 6.1648亿美元 |
| 市场规模:2031年 | 840,890,000 美元 |
| 复合年增长率:2026-2031年 | 5.31% |
| 成长最快的细分市场 | 间歇性导尿管 |
| 最大的市场 | 北美洲 |
然而,由于各医疗机构对标准化监测通讯协定的应用并不一致,市场存在许多障碍。许多医疗机构由于缺乏对压力管理标准的认识和训练不足,尚未采用这些专用导管。世界腹膜内压力症候群协会(WSACS)2024年的数据凸显了这个问题,数据显示,只有41%的医护人员将既定的腹腔内压力管理指引正式纳入日常诊疗实务。这种对诊断通讯协定的低依从性显着限制了市场的成长潜力。
推动先进膀胱容量压力计导管加速普及的主要动力之一是临床上日益重视降低导尿管相关尿道感染(CAUTI)的发生率。医疗机构越来越多地采用结合精确容量监测和压力管理的导管系统,以降低过度扩张和后续感染的风险。朝向更严格的感染控制和以价值为导向的医疗模式转变,正在实际改善病人安全。例如,美国疾病管制与预防中心(CDC)于2024年11月发布的《2023年国家和州医疗保健相关感染疾病进展报告》显示,2022年至2023年美国急诊医院的CAUTI病例减少了11%,这凸显了市场正向能够提供关键数据并降低感染风险的先进设备转变。
此外,膀胱功能障碍和尿失禁的日益普遍,使得慢性病照护和重症监护领域对可靠的监测解决方案的需求不断增长。随着全球膀胱相关疾病发生率的上升,对精准诊断工具的需求也日益迫切,以应对这些复杂的病例。 2024年9月,美国国家尿失禁协会(NAC)在新闻稿中指出,美国约有1亿女性患有尿失禁,凸显了庞大的患者族群亟需有效的治疗。不断扩大的患者群体直接推动了商业性成长。正如康维特集团2024年3月的报告所示,由于市场对其泌尿系统系统产品组合的强劲需求,该公司尿失禁护理业务实现了6.5%的有机收入成长。
标准化监测通讯协定实施不力是全球膀胱容量测量导管市场成长的主要障碍。儘管这些设备提供的腹腔内测压法精度很高,但由于普遍缺乏认识和员工培训不足,许多医疗机构无法将其纳入常规重症监护流程。当医护人员未能充分理解客观压力测量的必要性时,他们往往依赖主观的临床评估,而这些评估通常并不准确。这种对过时方法的依赖降低了人们对采购专用测压导管的紧迫感,从而阻碍了市场渗透,并限制了其普及率。
近期统计数据凸显了医学领域教育差距的严重性。根据2024年世界腹腔腔室症候群协会会议的数据,仅有59%的医护人员了解腹内高压管理的最新指引。这一数字表明,先进的诊断技术与实际临床实践之间存在显着差距。除非相当一部分目标使用者群体意识到腹压监测不足的危害,否则对膀胱容量压力计导管的需求将持续低迷,直接影响市场获利能力。
业界正经历着一场根本性的变革,即从间歇性的手动测量转向自动化的即时数据收集,实现腹腔内压力的连续监测。临床医生越来越倾向于选择能够提供动态分析的系统,以便早期发现腹腔内高压(IAH),而不再使用只能瞬时记录患者状况的静态模拟压力表。现代设备透过将尿量和压力测量整合到单一诊断流程中,简化了工作流程,从而推动了这一转变。 Accuryn Medical 在 2024 年 2 月发布的声明证实,其 Accuryn 监测系统已用于治疗约 7 万名患者,这反映了临床对即时生理数据的日益依赖,也印证了此类解决方案日益增长的需求。
另一个关键趋势是开发多功能智慧导尿管,将温度监测、压力感测和容量测量整合于单一设备中。这项创新源于对高精度诊断工具的需求,这些工具能够简化复杂外科手术和急诊护理环境中的病患管理。与传统的Foley导管不同,这些先进的系统无需使用多种侵入性器械,即可对尿道状况和膀胱功能全面评估。对这类整合泌尿系统技术的需求正在推动产业成长,科乐普公司2024年11月发布的报告也印证了这一点,该报告指出,该公司介入泌尿外科业务的有机收入在上一财年增长了5%。
The Global Bladder Volume Manometer Catheter Market is projected to expand from USD 616.48 Million in 2025 to USD 840.89 Million by 2031, reflecting a CAGR of 5.31%. These specialized medical instruments are designed to measure intra-abdominal pressure through the bladder, enabling the accurate diagnosis of conditions like intra-abdominal hypertension. By offering critical data for intensive care management and replacing unreliable clinical estimation techniques, these devices have become essential tools. The market is largely driven by the rising volume of intensive care admissions and the urgent need to prevent organ failure linked to high abdominal pressure, alongside a growing preference for minimally invasive monitoring solutions in trauma settings.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 616.48 MIllion |
| Market Size 2031 | USD 840.89 MIllion |
| CAGR 2026-2031 | 5.31% |
| Fastest Growing Segment | Intermittent Catheters |
| Largest Market | North America |
However, the market faces a substantial barrier due to the inconsistent application of standardized monitoring protocols across healthcare institutions. Many facilities have not adopted these specialized catheters, frequently due to a lack of awareness or insufficient training regarding pressure management standards. This issue is highlighted by 2024 data from the World Society of the Abdominal Compartment Syndrome, which indicated that only 41% of healthcare practitioners had formally integrated established guidelines for intra-abdominal pressure management into their daily practice. Such limited adherence to diagnostic protocols significantly restricts the market's potential for growth.
Market Driver
A primary factor accelerating the adoption of advanced bladder volume manometer catheters is the intensifying clinical focus on reducing Catheter-Associated Urinary Tract Infections (CAUTI). Healthcare institutions are increasingly favoring catheter systems that combine precise volume monitoring with pressure management to mitigate the risks of over-distension and subsequent infection. This transition toward strict infection control and value-based care has yielded tangible improvements in patient safety. For instance, the Centers for Disease Control and Prevention's '2023 National and State Healthcare-Associated Infections Progress Report', released in November 2024, noted an 11% decline in CAUTI cases within U.S. acute care hospitals between 2022 and 2023, underscoring the market shift toward sophisticated devices that reduce infection risks while providing vital data.
Additionally, the escalating prevalence of bladder dysfunction and urinary incontinence is boosting the demand for reliable monitoring solutions in both chronic and critical care environments. As the global incidence of bladder-related conditions grows, the need for accurate diagnostic tools to manage these complex cases becomes increasingly urgent. In September 2024, the National Association for Continence highlighted in a press release that nearly 100 million women in the U.S. suffer from urinary incontinence, emphasizing the massive population requiring effective management. This expanding patient base directly drives commercial growth, as evidenced by Convatec Group Plc's March 2024 report, which cited a 6.5% organic revenue increase in their Continence Care division due to strong demand for their urological portfolio.
Market Challenge
The inconsistent implementation of standardized monitoring protocols serves as a major impediment to the growth of the Global Bladder Volume Manometer Catheter Market. Despite the precision these devices offer in measuring intra-abdominal pressure, many medical facilities fail to integrate them into routine critical care due to a pervasive lack of awareness and inadequate staff training. When healthcare professionals do not fully appreciate the necessity of objective pressure measurement, they often revert to subjective clinical estimations, which are frequently inaccurate. This reliance on outdated methods diminishes the perceived urgency to procure specialized manometer catheters, thereby stalling market penetration and limiting adoption rates.
Recent statistics highlight the severity of this educational gap within the medical field. Data from the World Society of the Abdominal Compartment Syndrome in 2024 revealed that only 59% of healthcare practitioners were aware of current guidelines regarding the management of intra-abdominal hypertension. This figure underscores a significant disconnect between advanced diagnostic technology and actual clinical practice. As long as a substantial portion of the target user base remains uninformed about the dangers of unmonitored abdominal pressure, the demand for bladder volume manometer catheters will remain suppressed, directly hindering the market's revenue potential.
Market Trends
The industry is witnessing a fundamental shift toward continuous intra-abdominal pressure monitoring, replacing intermittent manual checks with automated, real-time data collection. Clinicians are increasingly moving away from static analog manometers, which offer only snapshots of a patient's status, in favor of systems that provide dynamic analytics for the early detection of intra-abdominal hypertension (IAH). This transition is supported by modern devices that streamline workflows by integrating urine output and pressure readings into a single diagnostic stream. The growing traction for such solutions is evident in Accuryn Medical's February 2024 announcement, which confirmed that their Accuryn Monitoring System has been used to treat nearly 70,000 patients, reflecting a rising clinical dependence on real-time physiological data.
Another dominant trend is the development of multi-parameter smart catheters, which converge temperature monitoring, pressure sensing, and volume measurement into a single device. This innovation is driven by the demand for high-fidelity diagnostic tools in interventional urology that simplify patient management in complex surgical and acute care settings. Unlike traditional Foley catheters, these advanced systems allow for comprehensive assessments of urethral integrity and bladder function without the need for multiple invasive instruments. This demand for integrated urological technologies is fueling sector growth, as reflected in Coloplast A/S's November 2024 report, which noted a 5% organic revenue increase in their Interventional Urology business for the fiscal year.
Report Scope
In this report, the Global Bladder Volume Manometer Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Bladder Volume Manometer Catheter Market.
Global Bladder Volume Manometer Catheter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: